DK0735890T3 - Blandinger af 2',3'-dideoxyinosin og hydroxycarbamid til hæmning af retroviral spredning - Google Patents

Blandinger af 2',3'-dideoxyinosin og hydroxycarbamid til hæmning af retroviral spredning

Info

Publication number
DK0735890T3
DK0735890T3 DK95909917T DK95909917T DK0735890T3 DK 0735890 T3 DK0735890 T3 DK 0735890T3 DK 95909917 T DK95909917 T DK 95909917T DK 95909917 T DK95909917 T DK 95909917T DK 0735890 T3 DK0735890 T3 DK 0735890T3
Authority
DK
Denmark
Prior art keywords
hydroxycarbamide
spread
dideoxyinosine
mixtures
retrovirus
Prior art date
Application number
DK95909917T
Other languages
Danish (da)
English (en)
Inventor
Serge D Malley
Raul Jorge Vila
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of DK0735890T3 publication Critical patent/DK0735890T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
DK95909917T 1993-12-20 1994-12-20 Blandinger af 2',3'-dideoxyinosin og hydroxycarbamid til hæmning af retroviral spredning DK0735890T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/169,253 US5521161A (en) 1993-12-20 1993-12-20 Method of treating HIV in humans by administration of ddI and hydroxycarbamide
PCT/IB1995/000153 WO1995017899A2 (en) 1993-12-20 1994-12-20 Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread

Publications (1)

Publication Number Publication Date
DK0735890T3 true DK0735890T3 (da) 2002-08-05

Family

ID=22614846

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95909917T DK0735890T3 (da) 1993-12-20 1994-12-20 Blandinger af 2',3'-dideoxyinosin og hydroxycarbamid til hæmning af retroviral spredning

Country Status (13)

Country Link
US (2) US5521161A (pt)
EP (1) EP0735890B1 (pt)
AT (1) ATE216245T1 (pt)
AU (1) AU1821295A (pt)
CA (1) CA2179627C (pt)
DE (1) DE69430440T2 (pt)
DK (1) DK0735890T3 (pt)
ES (1) ES2173948T3 (pt)
OA (1) OA10721A (pt)
PT (1) PT735890E (pt)
TW (1) TW283645B (pt)
WO (1) WO1995017899A2 (pt)
ZA (1) ZA949219B (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US6346627B1 (en) 1990-02-01 2002-02-12 Emory University Intermediates in the synthesis of 1,3-oxathiolane nucleoside enantiomers
SE9003151D0 (sv) * 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
EP0610444B1 (en) 1991-10-31 2003-01-29 ELFORD, Howard L. Use of a polyhydroxybenzamide or a derivative thereof in the manufacture of a medicament for treating viral infectious diseases
ATE273700T1 (de) * 1993-05-21 2004-09-15 Us Gov Health & Human Serv Neues verfahen zur hemmung der replication der virus - abhängigen reverse transciptase durch verwendung von dideoxydenucleotide-synthese inhibitoren
US6677310B1 (en) * 1999-04-21 2004-01-13 Nabi Ring-expanded nucleosides and nucleotides
US6093702A (en) * 1993-12-20 2000-07-25 The United States Of America As Represented By The Department Of Health And Human Services Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
US5521161A (en) * 1993-12-20 1996-05-28 Compagnie De Developpment Aguettant S.A. Method of treating HIV in humans by administration of ddI and hydroxycarbamide
AU688552B2 (en) * 1994-07-15 1998-03-12 Biosearch Italia S.P.A. Dinucleoside-5',5'-pyrophosphates
US6391859B1 (en) 1995-01-27 2002-05-21 Emory University [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
US5703058A (en) * 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6511848B2 (en) * 1996-04-17 2003-01-28 Winfried Albert Process for producing and multiplying lymphocytes
US5719132A (en) * 1996-06-27 1998-02-17 Bristol-Myers Squibb Company Compositions and methods of treating HIV with d4T, 5-fluorouracil/tegafur, and uracil
US5886165A (en) * 1996-09-24 1999-03-23 Hybridon, Inc. Mixed backbone antisense oligonucleotides containing 2'-5'-ribonucleotide- and 3'-5'-deoxyribonucleotides segments
US6218386B1 (en) 1996-11-08 2001-04-17 Dupont Pharmaceuticals A1-(3-aminoindazol-5-yl)-3 butyl-cyclic urea useful as a HIV protease inhibitor
US5932570A (en) * 1996-11-08 1999-08-03 Dupont Pharmaceuticals Company 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as HIV protease inhibitors
US6686462B2 (en) * 1997-02-28 2004-02-03 The Regents Of The University Of California Antiviral compounds and methods of administration
US6114312A (en) * 1997-03-07 2000-09-05 Research Institute For Genetic And Human Therapy (R.I.G.H.T.) Method of inhibiting human immunodeficiency virus by combined use of hydroxyurea, a nucleoside analog, and a protease inhibitor
CA2284483A1 (en) * 1997-03-20 1998-10-01 Compagnie De Developpement Aguettant Mixtures of at least two reverse transcriptase inhibitors and hydroxycarbamide, in particular for inhibiting retroviral spread
WO1998050347A1 (en) * 1997-05-05 1998-11-12 The Regents Of The University Of California Naphthols useful in antiviral methods
AU9016998A (en) 1997-08-08 1999-03-01 Newbiotics, Inc. Methods and compositions for overcoming resistance to biologic and chemotherapy
US20020022034A1 (en) * 1997-09-15 2002-02-21 Julianna Lisziewicz Therapeutic DNA vaccination
KR100286373B1 (ko) * 1997-10-17 2001-04-16 윤종용 적외선 데이터 통신을 위한 휴대용 컴퓨터
DK1045897T3 (da) 1998-01-23 2002-05-13 Newbiotics Inc Enzymatisk katalyserede, terapeutiske midler
US7462605B2 (en) * 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
US6015796A (en) * 1998-03-11 2000-01-18 Zeria Pharmaceutical Co., Ltd. Method for treating AIDS
US6251874B1 (en) * 1998-03-26 2001-06-26 Research Institute For Genetic And Human Therapy (R.I.G.H.T.) Method of inhibiting human immunodeficiency virus using hydroxurea and a reverse transcriptase inhibitor in vivo
MXPA00012842A (es) * 1998-06-24 2004-06-22 Univ Emory Uso de 3'-azido-2',3'-didesoxiuridina en combinacion de drogas adicionales contra el vih para la manufactura de un medicamento para el tratamiento del vih.
EP1146904A4 (en) * 1999-02-03 2004-09-15 Franco Lori USE OF HYDROXY URINE AND AN INHIBITOR OF REVERSE TRANSCRIPTASE FOR INDUCING AUTOVACCATION BY AUTOLOGICAL HIV
US6020325A (en) * 1999-03-09 2000-02-01 Zeria Pharmaceutical Co., Ltd. Method for inhibiting replication of HIV
WO2001007088A2 (en) 1999-07-22 2001-02-01 Newbiotics, Inc. Methods for treating therapy-resistant tumors
US6683061B1 (en) 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
CA2380924C (en) 1999-08-13 2008-02-19 University Of Maryland Biotechnology Institute Compositions for treating viral infections, and methods therefor
NL1012825C2 (nl) * 1999-08-13 2001-02-23 Faculteit Geneeskunde Universi Farmaceuticum voor de behandeling van virale infecties in het bijzonder van het humane immunodeficiency virus (HIV).
WO2002056832A2 (en) * 2001-01-19 2002-07-25 Newbiotics, Inc. Methods to treat autoimmune and inflammatory conditions
US20050250728A1 (en) * 2002-05-23 2005-11-10 Shanta Bantia Enhancing the efficacy of reverse transcriptase and dna polymerase inhibitors (nucleoside analogs) using pnp inhibitors and/or 2'-deoxyguanosine and/or prodrug thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
CA1314875C (en) * 1985-05-15 1993-03-23 George Walter Koszalka Therapeutic nucleosides
AU570853B2 (en) * 1985-08-26 1988-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases
US5110600A (en) * 1988-01-25 1992-05-05 The Regents Of The University Of California Method of treating viral infections with amino acid analogs
US5026687A (en) * 1990-01-03 1991-06-25 The United States Of America As Represented By The Department Of Health And Human Services Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds
US5300059A (en) * 1991-11-19 1994-04-05 Hydro Slip Technologies Inc. Bloodbag and method of making same
ATE273700T1 (de) * 1993-05-21 2004-09-15 Us Gov Health & Human Serv Neues verfahen zur hemmung der replication der virus - abhängigen reverse transciptase durch verwendung von dideoxydenucleotide-synthese inhibitoren
US5521161A (en) * 1993-12-20 1996-05-28 Compagnie De Developpment Aguettant S.A. Method of treating HIV in humans by administration of ddI and hydroxycarbamide

Also Published As

Publication number Publication date
ZA949219B (en) 1995-08-01
WO1995017899A3 (en) 1995-08-10
DE69430440D1 (de) 2002-05-23
OA10721A (en) 2002-12-09
US5521161A (en) 1996-05-28
WO1995017899A2 (en) 1995-07-06
ATE216245T1 (de) 2002-05-15
EP0735890A1 (en) 1996-10-09
DE69430440T2 (de) 2002-11-14
CA2179627C (en) 2000-02-22
TW283645B (pt) 1996-08-21
US5736527A (en) 1998-04-07
AU1821295A (en) 1995-07-17
ES2173948T3 (es) 2002-11-01
EP0735890B1 (en) 2002-04-17
PT735890E (pt) 2002-09-30
CA2179627A1 (en) 1995-07-06

Similar Documents

Publication Publication Date Title
DK0735890T3 (da) Blandinger af 2&#39;,3&#39;-dideoxyinosin og hydroxycarbamid til hæmning af retroviral spredning
MY119031A (en) Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses
DE3587434T2 (de) Antivirale pharmazeutische Zusammensetzungen und ihrer Verwendung.
BG60698B2 (en) Pharmaceutical ACCEPTABLE SALTS
MX9700237A (es) Combinaciones inhibidoras de proteasa retroviral.
DE69811062D1 (de) Polyaromatische antivirale zusammensetzungen
DE69427704D1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n-disubstituierte-amino-3,4-dihydro-2h-1-benzopyrane
GR3029370T3 (en) Compounds and methods for inhibition of hiv and related viruses
BR9711647A (pt) Novos derivados de ácido dicafeoilquìmico, seu uso, composições com os mesmos e métodos de tratamento usando-os.
ATE206916T1 (de) Zusammensetzungen zur erhöhung der konzentration und/oder beweglichkeit von samenzellen in menschen
DK153587A (da) Forbindelser med nootrop virkning, midler indeholdende disse og deres anvendelse ved behandling af forebyggelse af cognitive dysfunktioner
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.
ATE158947T1 (de) Hautregenerierende kosmetische zusammensetzung
MX9307203A (es) COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.
NO20001758L (no) FremgangsmÕter og blandinger for behandling av leddgikt
NO970573L (no) Ylidenforbindelser og deres fremstilling
AU567018B2 (en) Prazosin-pirbuterol combination for bronchoduation
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
ES2153584T3 (es) Piridiniminil-1,2-benzisoxazol y -benzisotiazol como antipsicoticos.
ES2065855B1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
DE69614127D1 (de) Eine familie von verbindungen mit entzündungshemmender und antiviraler aktivität und deren zusammensetzungen alleine oder in verbindung mit inhibitoren der reversen transcriptase zur inhibierung, vermeidung oder eliminierung viraler replikation und methoden zu ihrer verwendung
WO1995017875A3 (en) MIXTURES OF DIDEOXYNUCLEOSIDES AND D-ASPARTIC ACID β-HYDROXAMATE FOR INHIBITING RETROVIRAL SPREAD
MX9701606A (es) Terapia de combinacion para evitar la perdida osea-progesterona y agonistas de estrogeno.
GB9814039D0 (en) Materials and methods relating to the prevention or treatment of ischaemia-reperfusion injury
DK381983A (da) Fremgangsmaade til fremstilling af spiro(2h-1,4-benzodioxepin-3(5h)4&#39;-piperidin- og -3&#39;-pyrrolidinforbindelser